EGFR and lung adenocarcinoma: To investigate fusion genes in lung cancer, we analysed RNA-sequencing data of 29 patients with lung adenocarcinoma (NCCLUAD) who lacked activating mutations in KRAS or EGFR (Supplementary Table 1).